We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+6.13%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$995M
AUM Growth
+$58.3M
Cap. Flow
+$1.53M
Cap. Flow %
0.15%
Top 10 Hldgs %
31.03%
Holding
293
New
25
Increased
75
Reduced
95
Closed
36

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$11.7M
2
Y
Alleghany Corp
Y
+$6.27M
3
AON icon
Aon
AON
+$4.05M
4
MTRX icon
Matrix Service
MTRX
+$3.45M
5
SON icon
Sonoco
SON
+$2.78M

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$11.3M
2
AGN
Allergan plc
AGN
+$5.47M
3
COHR icon
Coherent
COHR
+$2.22M
4
MET icon
MetLife
MET
+$2.02M
5
MOS icon
The Mosaic Company
MOS
+$1.83M

Sector Composition

Rank Sector Weight
1 Technology 21.63%
2 Industrials 15.17%
3 Healthcare 14.09%
4 Financials 13.25%
5 Consumer Discretionary 12.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIN
151
Aberdeen Intermediate Income Fund
MIN
$273M
-140,150
Closed -$603K
ITT icon
152
ITT
ITT
$17.5B
$586K 0.06%
13,240
-102
-0.8% -$4.2K
ADP icon
153
Automatic Data Processing
ADP
$100B
$572K 0.06%
5,228
SPY icon
154
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$563K 0.06%
2,241
+65
+3% +$16K
ORBK
155
DELISTED
Orbotech Ltd
ORBK
$558K 0.06%
13,225
-750
-5% -$28.6K
ED icon
156
Consolidated Edison
ED
$41.6B
$541K 0.05%
6,700
-440
-6% -$36.4K
KMM
157
DELISTED
Deutsche Multi-Market Incm Trust
KMM
-58,600
Closed -$519K
KO icon
158
Coca-Cola
KO
$354B
$530K 0.05%
11,773
RAND icon
159
Rand Capital
RAND
$528K 0.05%
19,960
+2,038
+11% +$52.3K
GV
160
DELISTED
Goldfield Corporation
GV
$515K 0.05%
81,745
+7,500
+10% +$38.2K
PFL
161
PIMCO Income Strategy Fund
PFL
$381M
-39,900
Closed -$482K
KERX
162
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$500K 0.05%
70,400
MYN icon
163
BlackRock MuniYield New York Quality Fund
MYN
$374M
-30,000
Closed -$397K
COP icon
164
ConocoPhillips
COP
$147B
$493K 0.05%
9,850
+500
+5% +$22.5K
LLL
165
DELISTED
L3 Technologies, Inc.
LLL
$490K 0.05%
2,600
DAR icon
166
Darling Ingredients
DAR
$9.93B
$474K 0.05%
27,082
-375
-1% -$6.35K
GATX icon
167
GATX Corp
GATX
$6.55B
$474K 0.05%
7,700
-1,500
-16% -$92.3K
BIIB icon
168
Biogen
BIIB
$29.9B
$470K 0.05%
+1,500
New +$444K
IJR icon
169
iShares Core S&P Small-Cap ETF
IJR
$109B
$465K 0.05%
6,264
IWF icon
170
iShares Russell 1000 Growth ETF
IWF
$122B
$463K 0.05%
14,816
+7,336
+98% +$225K
GENC icon
171
Gencor Industries
GENC
$223M
$459K 0.05%
26,023
+523
+2% +$8.43K
TEVA icon
172
Teva Pharmaceuticals
TEVA
$35.9B
$457K 0.05%
25,944
-29,157
-53% -$656K
PDCE
173
DELISTED
PDC Energy, Inc.
PDCE
$456K 0.05%
9,300
DHI icon
174
D.R. Horton
DHI
$41B
$455K 0.05%
11,400
-50
-0.4% -$1.82K
CDE icon
175
Coeur Mining
CDE
$15.6B
$454K 0.05%
49,400
+2,000
+4% +$17K

Similar funds

Shufro Rose & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Shufro Rose & Co held 293 positions worth $995M, up 6.2% from $936M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Shufro Rose & Co's Q3 2017 filing shows 25 new, 75 increased, 95 reduced and 36 closed positions. Its largest new stake was Alleghany Corp: 10,755 shares worth $5.96M. The largest sale was Du Pont De Nemours E I, an estimated $11.3M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Shufro Rose & Co's largest Q3 2017 buy was Alleghany Corp: 10,755 shares worth $5.96M.
  • Shufro Rose & Co added most to DuPont de Nemours in Q3 2017, an estimated $11.7M increase.
  • Shufro Rose & Co's biggest Q3 2017 reduction was Allergan plc, cutting an estimated $5.47M.
  • Shufro Rose & Co fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $11.3M.
  • Shufro Rose & Co's ten largest holdings make up 31% of its $995M portfolio in Q3 2017.
  • Shufro Rose & Co opened 25 new positions and closed 36 in Q3 2017.
  • Shufro Rose & Co's portfolio value rose 6.2% quarter-over-quarter to $995M.

Based on Shufro Rose & Co's 13F filing for Q3 2017, filed 13 Nov 2017.